Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 10/20 | 1.00 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.58 |
| ▸ | PIM1 | P11309 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | GSK3A | P49840 | 2/20 | 0.58 |
| ▸ | GSK3B | P49841 | 2/20 | 0.58 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.58 |
| ▸ | STK3 | Q13188 | 2/20 | 0.58 |
| ▸ | CDC42BPA | Q5VT25 | 2/20 | 0.58 |
| ▸ | FLT3 | P36888 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.58 |
| ▸ | CDK2 | P24941 | 1/20 | 0.58 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.58 |
| ▸ | FRK | P42685 | 1/20 | 0.58 |
| ▸ | CLK2 | P49760 | 1/20 | 0.58 |
| ▸ | CAMK2B | Q13554 | 1/20 | 0.58 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4851373 | 0.86 | CSF1R (0.75) | CSF1RKDM4EPADI4MAPT | |
| SCHEMBL4849550 | 0.85 | CSF1R (0.74) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4851140 | 0.83 | CSF1R (0.76) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4845930 | 0.83 | CSF1R (1.00) | CSF1RFLT3PADI4KIT | |
| SCHEMBL4851389 | 0.81 | CSF1R (1.00) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4847486 | 0.81 | CSF1R (0.68) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4852694 | 0.81 | CSF1R (0.67) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4844229 | 0.78 | CSF1R (0.64) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4849267 | 0.78 | CSF1R (0.69) | CSF1RROCK2PIM1MAPK1GSK3A | |
| SCHEMBL4849726 | 0.77 | CSF1R (0.67) | CSF1RROCK2PIM1MAPK1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110136796-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-06-09 | — | — | US | claimed |
| EP-2291187-A2 | IDO INHIBITORS | Newlink Genetics (US) | 2011-03-09 | — | — | EP | claimed |
| WO-2009132238-A2 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2009-10-29 | — | — | WO | claimed |
| US-9174942-B2 | IDO inhibitors | NEWLINK GENETICS CORPORATION (US) | 2015-11-03 | — | — | US | disclosed |
| US-20140323740-A1 | IDO Inhibitors | NEWLINK GENETICS CORPORATION (US) | 2014-10-30 | — | — | US | disclosed |
| US-8748469-B2 | IDO inhibitors | NEWLINK GENETICS CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| US-20110136796-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-06-09 | — | — | US | disclosed |
| EP-2291187-A2 | IDO INHIBITORS | Newlink Genetics (US) | 2011-03-09 | — | — | EP | disclosed |
| WO-2009132238-A2 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2009-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323740-A1 | IDO Inhibitors | IDO1, IDO2, INMT | CSF1R 610/4885ROCK2 1467/4885PIM1 1794/4885 |
| US-20110136796-A1 | IDO Inhibitors | IDO1, IDO2, INMT | CSF1R 610/4885ROCK2 1467/4885PIM1 1794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.